MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · IEX Real-Time Price · USD
4.920
-0.100 (-1.99%)
At close: Jul 19, 2024, 4:00 PM
4.800
-0.120 (-2.44%)
Pre-market: Jul 22, 2024, 4:46 AM EDT
MacroGenics Revenue
MacroGenics had revenue of $43.36M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $9.10M. In the year 2023, MacroGenics had annual revenue of $58.75M.
Revenue (ttm)
$43.36M
Revenue Growth
-73.78%
P/S Ratio
7.11
Revenue / Employee
$127,897
Employees
339
Market Cap
308.16M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 58.75M | -93.19M | -61.33% |
Dec 31, 2022 | 151.94M | 74.49M | 96.19% |
Dec 31, 2021 | 77.45M | -27.44M | -26.16% |
Dec 31, 2020 | 104.88M | 40.70M | 63.40% |
Dec 31, 2019 | 64.19M | 4.07M | 6.76% |
Dec 31, 2018 | 60.12M | -97.62M | -61.89% |
Dec 31, 2017 | 157.74M | 65.86M | 71.68% |
Dec 31, 2016 | 91.88M | -8.97M | -8.90% |
Dec 31, 2015 | 100.85M | 53.06M | 111.00% |
Dec 31, 2014 | 47.80M | -10.24M | -17.64% |
Dec 31, 2013 | 58.04M | -5.79M | -9.07% |
Dec 31, 2012 | 63.83M | 6.62M | 11.57% |
Dec 31, 2011 | 57.21M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
DocGo | 703.37M |
OraSure Technologies | 304.64M |
Aurora Cannabis | 253.96M |
Sutro Biopharma | 154.07M |
Pulmonx | 72.99M |
Enanta Pharmaceuticals | 72.88M |
Nyxoah | 5.57M |
Opthea | 385.28K |
MGNX News
- 11 minutes ago - MacroGenics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - MGNX - Accesswire
- 2 days ago - ATTENTION MacroGenics, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights - Accesswire
- 2 days ago - MacroGenics Incorporated Stockholders Are Encouraged By The Schall Law Firm To Reach Out Amidst Ongoing Investigation - Accesswire
- 2 days ago - MacroGenics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - MGNX - Accesswire
- 2 days ago - Investigation Into MacroGenics (MGNX) Announced by Hagens Berman - GlobeNewsWire
- 3 days ago - Levi & Korsinsky Reminds Shareholders of an Investigation into MacroGenics, Inc. (MGNX) Regarding Potential Securities Fraud Allegations - Accesswire
- 3 days ago - The Schall Law Firm Is Investigating MacroGenics Incorporated And Encourages Its Stockholders To Connect - Accesswire
- 4 days ago - Shareholders that lost money on MacroGenics, Inc. (MGNX) should contact Levi & Korsinsky about Securities Fraud Investigation - MGNX - Accesswire